Diphenyl diselenide reduces inflammation in the mouse model of pleurisy induced by carrageenan: reduction of pro-inflammatory markers and reactive species levels

2012 ◽  
Vol 61 (10) ◽  
pp. 1117-1124 ◽  
Author(s):  
Cristiane Luchese ◽  
Marina Prigol ◽  
Marta M. M. F. Duarte ◽  
Cristina W. Nogueira
2020 ◽  
pp. 1-14
Author(s):  
Yaser H.A. Elewa ◽  
Osamu Ichii ◽  
Teppei Nakamura ◽  
Yasuhiro Kon

Diabetes is a devastating global health problem and is considered a predisposing factor for lung injury progression. Furthermore, previous reports of the authors revealed the role of mediastinal fat-associated lymphoid clusters (MFALCs) in advancing respiratory diseases. However, no reports concerning the role of MFALCs on the development of lung injury in diabetes have been published. Therefore, this study aimed to examine the correlations between diabetes and the development of MFALCs and the progression of lung injury in a streptozotocin-induced diabetic mouse model. Furthermore, immunohistochemical analysis for immune cells (CD3+ T-lymphocytes, B220+ B-lymphocytes, Iba1+ macrophages, and Gr1+ granulocytes), vessels markers (CD31+ endothelial cells and LYVE-1+ lymphatic vessels “LVs”), and inflammatory markers (TNF-α and IL-5) was performed. In comparison to the control group, the diabetic group showed lung injury development with a significant increase in MFALC size, immune cells, LVs, and inflammatory marker, and a considerable decrease of CD31+ endothelial cells in both lung and MFALCs was observed. Furthermore, the blood glucose level showed significant positive correlations with MFALCs size, lung injury, immune cells, inflammatory markers, and LYVE-1+ LVs in lungs and MFALCs. Thus, we suggest that the development of MFALCs and LVs could contribute to lung injury progression in diabetic conditions.


2018 ◽  
Vol 46 ◽  
pp. 17-25 ◽  
Author(s):  
Marcel Henrique Marcondes Sari ◽  
Vanessa Angonesi Zborowski ◽  
Luana Mota Ferreira ◽  
Natália da Silva Jardim ◽  
Paulo Cesar Oliveira Araujo ◽  
...  

2018 ◽  
Vol 98 ◽  
pp. 801-805 ◽  
Author(s):  
Khalid M. Alkharfy ◽  
Ajaz Ahmad ◽  
Basit L. Jan ◽  
Mohammad Raish

Cytokine ◽  
2014 ◽  
Vol 66 (1) ◽  
pp. 60-68 ◽  
Author(s):  
J.L. Steiner ◽  
J.M. Davis ◽  
J.L. McClellan ◽  
A. Guglielmotti ◽  
E.A. Murphy

2015 ◽  
Vol 308 (12) ◽  
pp. G1012-G1018 ◽  
Author(s):  
Anna Pérez-Bosque ◽  
Lluïsa Miró ◽  
Mònica Maijó ◽  
Javier Polo ◽  
Joy Campbell ◽  
...  

Dietary supplementation with immunoglobulins from animal plasma has anti-inflammatory effects on intestinal and lung models of acute inflammation. Here, we aimed to establish whether dietary intervention with serum-derived bovine immunoglobulin (SBI) can prevent alterations in intestinal barrier function in a mouse model with a genetic predisposition to inflammatory bowel disease (IBD). Wild-type (WT) mice and mice lacking the mdr1a gene (KO) were fed diets supplemented with either SBI (2% wt/wt) or milk proteins (control diet), from day 21 (weaning) until day 56. The epithelial permeability of distal colon crypts was measured by confocal microscopy using a fluorescent marker. The expression of junctional epithelial E-cadherin and β-catenin proteins were determined by Western blot and zonula occludens-1 (ZO-1) by immunofluorescence. Mucins (MUC1, MUC2, MUC4), TFF3, cytokines (TNF-α, IFN-γ), and inducible nitric oxide synthase RNA expression were quantified by real-time PCR. SBI blocked the increase in colon crypt permeability and partially prevented the reduction in E-cadherin and ZO-1 expression that characterize the KO mouse model (both P < 0.05). SBI inclusion also reduced the mucosal expression of the inflammatory markers TNF-α, IFN-γ, and inducible nitric oxide synthase (all P < 0.005). The number of goblet cells in the colon of KO mice was low and correlated well with MUC2 and TFF3 expression ( P < 0.001), whereas dietary supplementation with SBI attenuated these effects (all P < 0.05). In short, dietary SBI ameliorated colonic barrier alterations and reduced the expression of mucosal inflammatory markers in a genetic model of IBD.


2014 ◽  
Vol 390 (1-2) ◽  
pp. 1-8 ◽  
Author(s):  
Viviane Glaser ◽  
Roberta de Paula Martins ◽  
Ana Julia Hoffmann Vieira ◽  
Eliana de Medeiros Oliveira ◽  
Marcos Raniel Straliotto ◽  
...  

2021 ◽  
Vol 167 ◽  
pp. 106011
Author(s):  
Estevan Sonego Zimmermann ◽  
Luana Mota Ferreira ◽  
Laura Bedin Denardi ◽  
Marcel Henrique Marcondes Sari ◽  
Verônica Ferrari Cervi ◽  
...  

2013 ◽  
Vol 206 (1) ◽  
pp. 18-26 ◽  
Author(s):  
Viviane Glaser ◽  
Bettina Moritz ◽  
Ariana Schmitz ◽  
Alcir Luiz Dafré ◽  
Evelise Maria Nazari ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document